Clinical Trial Update: Clinical Study of DA-002 and DA-005 As a Treatment for Hair Loss [Phase 3]

View source ↗

Summary

This entry describes a Phase 3 clinical study evaluating DA-002 and DA-005 for hair loss conditions, including androgenetic alopecia and male/female pattern bal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia
• Female Pattern Baldness
• Male Pattern Baldness

Drugs mentioned

• DA-002
• DA-005

Snippet

Sponsor: Applied Biology, Inc. | Conditions: Androgenetic Alopecia, Female Pattern Baldness | Phase 3 | Status: NOT_YET_RECRUITING